Prelude Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-5,352
| Closed | -$514K | – | 1442 |
|
|
2025
Q4 | $514K | Buy |
+5,352
| New | +$520K | 0.04% | 518 |
|
|
2025
Q2 | – | Sell |
-2,681
| Closed | -$241K | – | 1212 |
|
|
2025
Q1 | $241K | Sell |
2,681
-656
| -20% | -$58.7K | 0.02% | 818 |
|
|
2024
Q4 | $267K | Sell |
3,337
-744
| -18% | -$64.4K | 0.02% | 853 |
|
|
2024
Q3 | $367K | Buy |
+4,081
| New | +$343K | 0.02% | 757 |
|
|
2024
Q2 | – | Sell |
-45,942
| Closed | -$4M | – | 1386 |
|
|
2024
Q1 | $4M | Buy |
+45,942
| New | +$3.92M | 0.21% | 89 |
|
|
2022
Q3 | – | Sell |
-7,181
| Closed | -$644K | – | 1789 |
|
|
2022
Q2 | $644K | Buy |
+7,181
| New | +$728K | 0.02% | 685 |
|
|
2022
Q1 | – | Sell |
-12,029
| Closed | -$1.24M | – | 2064 |
|
|
2021
Q4 | $1.24M | Buy |
12,029
+5,084
| +73% | +$589K | 0.03% | 506 |
|
|
2021
Q3 | $871K | Buy |
6,945
+3,907
| +129% | +$506K | 0.02% | 624 |
|
|
2021
Q2 | $377K | Buy |
+3,038
| New | +$381K | 0.01% | 1091 |
|
|
2020
Q1 | – | Sell |
-344
| Closed | -$36.6K | – | 1791 |
|
|
2019
Q4 | $39K | Sell |
344
-1,591
| -82% | -$175K | ﹤0.01% | 1425 |
|
|
2019
Q3 | $210K | Sell |
1,935
-1,223
| -39% | -$128K | 0.01% | 752 |
|
|
2019
Q2 | $308K | Sell |
3,158
-15,210
| -83% | -$1.39M | 0.02% | 608 |
|
|
2019
Q1 | $1.67M | Sell |
18,368
-4,377
| -19% | -$392K | 0.09% | 224 |
|
|
2018
Q4 | $2.07M | Buy |
22,745
+17,960
| +375% | +$1.68M | 0.14% | 160 |
|
|
2018
Q3 | $471K | Buy |
4,785
+1,135
| +31% | +$105K | 0.03% | 541 |
|
|
2018
Q2 | $312K | Buy |
+3,650
| New | +$305K | 0.02% | 661 |
|
|
2017
Q3 | – | Sell |
-31,341
| Closed | -$2.78M | – | 1794 |
|
|
2017
Q2 | $2.78M | Buy |
+31,341
| New | +$2.64M | 0.26% | 77 |
|
|
2016
Q4 | – | Sell |
-11,672
| Closed | -$1.01M | – | 1687 |
|
|
2016
Q3 | $1.01M | Sell |
11,672
-4,826
| -29% | -$421K | 0.11% | 210 |
|
|
2016
Q2 | $1.43M | Buy |
16,498
+3,008
| +22% | +$243K | 0.2% | 132 |
|
|
2016
Q1 | $1.01M | Buy |
+13,490
| New | +$1.02M | 0.14% | 169 |
|
|
2015
Q3 | – | Sell |
-13,973
| Closed | -$1.03M | – | 1651 |
|
|
2015
Q2 | $1.03M | Buy |
+13,973
| New | +$1.07M | 0.14% | 172 |
|
|
2015
Q1 | – | Sell |
-4,665
| Closed | -$337K | – | 2063 |
|
|
2014
Q4 | $337K | Sell |
4,665
-1,017
| -18% | -$70.6K | 0.05% | 453 |
|
|
2014
Q3 | $352K | Sell |
5,682
-2,369
| -29% | -$151K | 0.05% | 499 |
|
|
2014
Q2 | $513K | Buy |
8,051
+1,513
| +23% | +$91.9K | 0.07% | 367 |
|
|
2014
Q1 | $402K | Buy |
6,538
+1,388
| +27% | +$80.8K | 0.05% | 483 |
|
|
2013
Q4 | $296K | Buy |
5,150
+5,010
| +3,579% | +$284K | 0.05% | 506 |
|
|
2013
Q3 | $7K | Buy |
+140
| New | +$7.53K | ﹤0.01% | 1371 |
|
Other funds holding MDT
Prelude Capital Management's MDT Position: Q1 2026 in Review
Prelude Capital Management sold out of Medtronic (MDT) in Q1 2026, closing a stake of 5,352 shares — an estimated $514K sold.
Prelude Capital Management first reported a position in MDT in Q3 2013 and held it in 27 quarters. The position peaked at $4M in Q1 2024. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Prelude Capital Management reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
- Prelude Capital Management sold 5,352 Medtronic shares in Q1 2026, an estimated $514K.
- Prelude Capital Management first reported a position in Medtronic in Q3 2013 and held it in 27 quarters.
- Prelude Capital Management's Medtronic position peaked at $4M in Q1 2024.
- 2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.